Correlation Between FrontView REIT, and SIMCERE PHARMAC

Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and SIMCERE PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and SIMCERE PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FrontView REIT, and SIMCERE PHARMAC GRP, you can compare the effects of market volatilities on FrontView REIT, and SIMCERE PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of SIMCERE PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and SIMCERE PHARMAC.

Diversification Opportunities for FrontView REIT, and SIMCERE PHARMAC

0.36

Correlation Coefficient

FrontView REIT,  SIMCERE PHARMAC

Weak diversification

The 3 months correlation between FrontView and SIMCERE is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and SIMCERE PHARMAC GRP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIMCERE PHARMAC GRP and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with SIMCERE PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIMCERE PHARMAC GRP has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and SIMCERE PHARMAC go up and down completely randomly.

Pair Corralation between FrontView REIT, and SIMCERE PHARMAC

Considering the 90-day investment horizon FrontView REIT, is expected to under-perform the SIMCERE PHARMAC. But the stock apears to be less risky and, when comparing its historical volatility, FrontView REIT, is 2.16 times less risky than SIMCERE PHARMAC. The stock trades about 0.0 of its potential returns per unit of risk. The SIMCERE PHARMAC GRP is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  60.00  in SIMCERE PHARMAC GRP on September 27, 2024 and sell it today you would earn a total of  21.00  from holding SIMCERE PHARMAC GRP or generate 35.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	22.88%
Values	Daily Returns

FrontView REIT,  vs.  SIMCERE PHARMAC GRP

FrontView REIT,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FrontView REIT, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

SIMCERE PHARMAC GRP

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in SIMCERE PHARMAC GRP are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, SIMCERE PHARMAC may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with FrontView REIT, and SIMCERE PHARMAC

The main advantage of trading using opposite FrontView REIT, and SIMCERE PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, SIMCERE PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIMCERE PHARMAC will offset losses from the drop in SIMCERE PHARMAC's long position.

The idea behind FrontView REIT, and SIMCERE PHARMAC GRP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.